New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major revisions in the Phase III clinical trial protocol submitted by ...
Mindmachines.com has expanded the capabilities of its ROSHIWave IN-SIGHT Mind Machine with advanced brainwave disentrainment protocols designed to help users achieve deeper meditative states and ...
Coral Protocol’s multi-agent system achieved high performance on the GAIA Benchmark, with internal testing indicating a potential 34% performance gain. This result suggests an alternative to vertical ...
A recent analysis indicated that switching from the standard-dose inactivated influenza vaccine to the recombinant influenza vaccine (RIV) could have prevented nearly 100,000 hospitalizations among ...
Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China The modified vaccinia virus Ankara (MVA) is approved for use as a smallpox and monkeypox virus vaccine and was ...
School of Natural Sciences, University of Kent, Canterbury, United Kingdom Delivery of DNA into nucleated eukaryotic cells is known as transfection and has been essential in establishing technologies ...
- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...
Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe ...
Recombinant quadrivalent influenza vaccine (RIV4) and standard egg-based quadrivalent inactivated IV (IIV4) show comparable effectiveness in reducing influenza-related hospitalization among older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback